All headings › Chapter 29 › 2937
Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced… (HTS 2937) duty rate from China
Goods in HTS heading 2937 (Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced…) from China pay the general duty in the tariff schedule, and the rules in our table add nothing on top. Across the 29 lines below the percentage total runs from 0% to 0%. Section 232 is added to the totals only where a plain percentage applies to the line and the country (conditional and country-deal rates are listed, not added), we found no IEEPA duty in force, and antidumping duties are not checked here.
Duty by line
Pick your own 10-digit code from your classification or broker: the rate that applies to you is the one on your line. The last column is the percentage part only, on $10,000 of customs value.
| Code | Product | General rate | Added duties | Total percentage | On $10,000 |
|---|---|---|---|---|---|
| 2937.11.00.00 | Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues › Somatotropin, its derivatives and structural analogues | Free | none in our table | 0% | $0.00 |
| 2937.12.00.00 | Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues › Insulin and its salts | Free | none in our table | 0% | $0.00 |
| 2937.19.00.00 | Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues › Other | Free | none in our table | 0% | $0.00 |
| 2937.21.00.10 | Cortisone, hydrocortisone, prednisone (dehydrocortisone), and prednisolone (dehydrohydrocortisone) › Cortisone | Free | none in our table | 0% | $0.00 |
| 2937.21.00.20 | Cortisone, hydrocortisone, prednisone (dehydrocortisone), and prednisolone (dehydrohydrocortisone) › Hydrocortisone | Free | none in our table | 0% | $0.00 |
| 2937.21.00.30 | Cortisone, hydrocortisone, prednisone (dehydrocortisone), and prednisolone (dehydrohydrocortisone) › Prednisone | Free | none in our table | 0% | $0.00 |
| 2937.21.00.40 | Cortisone, hydrocortisone, prednisone (dehydrocortisone), and prednisolone (dehydrohydrocortisone) › Prednisolone | Free | none in our table | 0% | $0.00 |
| 2937.22.00.10 | Halogenated derivatives of adrenal cortical hormones › Dexamethasone (INN) and its salts | Free | none in our table | 0% | $0.00 |
| 2937.22.00.90 | Halogenated derivatives of adrenal cortical hormones › Other | Free | none in our table | 0% | $0.00 |
| 2937.23.10.10 | Obtained directly or indirectly from animal or vegetable materials › Estrogens | Free | none in our table | 0% | $0.00 |
| 2937.23.10.20 | Obtained directly or indirectly from animal or vegetable materials › Progesterone | Free | none in our table | 0% | $0.00 |
| 2937.23.10.50 | Obtained directly or indirectly from animal or vegetable materials › Other | Free | none in our table | 0% | $0.00 |
| 2937.23.25.00 | Estrogens and progestins › Estradiol benzoate; and Estradiol cyclopentylpropionate (Estradiol cypionate) | Free | none in our table | 0% | $0.00 |
| 2937.23.50.10 | Other › Estrogens | Free | none in our table | 0% | $0.00 |
| 2937.23.50.20 | Other › Progesterone | Free | none in our table | 0% | $0.00 |
| 2937.23.50.50 | Other › Other | Free | none in our table | 0% | $0.00 |
| 2937.29.10.00 | Other › Desonide; andNandrolone phenproprionate | Free | none in our table | 0% | $0.00 |
| 2937.29.90.20 | Other › Salts and esters of hydrocortisone | Free | none in our table | 0% | $0.00 |
| 2937.29.90.30 | Other › Salts and esters of prednisone | Free | none in our table | 0% | $0.00 |
| 2937.29.90.40 | Other › Salts and esters of prednisolone | Free | none in our table | 0% | $0.00 |
| 2937.29.90.50 | Other › Anabolic agents and androgens | Free | none in our table | 0% | $0.00 |
| 2937.29.90.95 | Other › Other | Free | none in our table | 0% | $0.00 |
| 2937.50.00.00 | Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones › Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues | Free | none in our table | 0% | $0.00 |
| 2937.90.05.00 | Catecholamine hormones, their derivatives and structural analogues › Epinephrine | Free | none in our table | 0% | $0.00 |
| 2937.90.10.00 | Other › Epinephrine hydrochloride | Free | none in our table | 0% | $0.00 |
| 2937.90.20.00 | Other › Other | Free | none in our table | 0% | $0.00 |
| 2937.90.40.00 | Amino-acid derivatives › l-Thyroxine (Levothyroxine), sodium | Free | none in our table | 0% | $0.00 |
| 2937.90.45.00 | Amino-acid derivatives › Other | Free | none in our table | 0% | $0.00 |
| 2937.90.90.00 | Other › Other | Free | none in our table | 0% | $0.00 |
What is and is not counted
| Layer | Status | Note |
|---|---|---|
| General (column 1) duty | Included | USITC Harmonized Tariff Schedule 2026HTSRev23 |
| Section 301 | Included where a rule in our table applies | China's older lists (Lists 1, 2, 3, 4A and the 2024 four-year-review increases) are loaded by product code with the exclusions now in force; the 2026 country action is loaded by country, with set totals for the EU, Japan, South Korea, Switzerland and Taiwan. Country-specific exemption lists (USMCA goods, CAFTA-DR textiles, UK and EU lists) are not modelled. Confirm each line with a broker. USTR: Section 301 investigations · USITC Harmonized Tariff Schedule, chapter 99 |
| Section 232 | Partly included: plain-percentage rows are added, conditional and country-deal rates are shown but not added | Plain-percentage rows from the USITC chapter 99 notes are added, one row per line (vehicles and parts ahead of metals ahead of wood); conditional and country-deal rates are listed, not added. Light-vehicle parts and truck parts are both 25% and the schedule does not say whether a part on both lists pays once or twice: the site shows one. Official source: CBP: Section 232 steel and aluminum FAQs · Commerce (BIS): Section 232 investigations |
| IEEPA / reciprocal | Checked: none in force found | We found no IEEPA or reciprocal duty in force. The nine IEEPA tariff actions named in Executive Order 14389 were ended by it (signed 2026-02-20), and the temporary 10% Section 122 surcharge that followed was set to expire on 2026-07-24 with no extension found in the Federal Register. A Section 301 action that began on 2026-07-24 is counted in the Section 301 layer above. Canada has a separate Section 338 duty on some products; we cannot say which lines. Official source: Federal Register: Executive Order 14389, Ending Certain Tariff Actions · Federal Register: Proclamation 11012, temporary import surcharge · CBP: IEEPA tariff FAQs |
| Antidumping / countervailing (AD/CVD) | 2 may apply | Antidumping and countervailing duty orders that MAY apply (2):
|
Section 232: what the proclamations say about chapter 29
These are summaries of the official proclamations. Where the tariff schedule notes give a plain percentage for your line and country, it is already in the duty above (see the layer list). Rates that depend on a fact only you know (the share of metal by weight, U.S.-made metal, a country deal, a USMCA claim) are listed but not added. Check your own line against the official list or ask your broker.
Pharmaceuticals and pharmaceutical ingredients in force
- Proclamation 11020 (2026-04-09). USITC HTS 2026HTSRev23, U.S. note 40 and headings 9903.04.60 to 9903.04.70. Patented pharmaceutical articles: total rate 100% (heading 9903.04.60); 15% total for products of Japan, the EU, South Korea, Switzerland and Liechtenstein (9903.04.62); the United Kingdom +0% (9903.04.63); +20% for companies with an approved onshoring plan (9903.04.64). Generic products, orphan drugs, nuclear medicines, plasma therapies, fertility treatments, cell and gene therapies, clinical-trial products and several other groups pay nothing extra (9903.04.61, .65 to .70).
- Product list (added 2026-11-21): 149 code prefixes parsed from note 40(c) (chapters 29 and 30). Whether the duty applies depends on patent status and the importer, which the product code cannot show, so every row is listed and none is added to totals. The pack holds neither chapter 29 nor chapter 30, so no tariff line of the site resolves to these rows yet.
Read from the proclamation on 2026-11-21. Sources: Proclamation 11020 (Federal Register document 2026-06956)